Philadelphia Pharmacovigilance

World’s greatest minds in drug safety, pharmacovigilance, data analysis, reporting, government policy, and innovative technology united under the Why Summits Future of Pharmacovigilance World Tour

key information



This is not just another Drug safety conference. This is a conference which tells you a STORY. One personal experience followed by another, a storyline of exceptional people who happen to choose Drug Safety and Pharmacovigilance as their way to bring needed medicines and protect those who are the most vulnerable, and to improve the health of millions of people on our planet. You will hear experts talk about the current issues in this ever-evolving industry. The best practice case studies on how to integrate new, disruptive technology into the rather rigid processes of PV organization and how it evolves to stay compliant. But how to do this with the more and more restrictive budget? How to prioritize, what methodologies to use for advanced therapies? What is the next evolution step in signal detection noise clearance? Are A.I.-based tools to become our colleagues, helpmates, or our replacement? Nonetheless, each company, department, and project starts with people. But how to build a winning cross-functional team and what kind of workforce is necessary for a drug safety department of the future? What kind of skills to expect from millennials and gen-z entering the industry and why do we need veterans in the industry as well? Challenges with innovations, outsourcing, everchanging regulatory landscape, harmonization, teaching other departments on how to use RWE data, and engaging the more and more aware public. All these topics we address, are conveyed having our mission in our mind, bringing medicines and new therapeutic indications to patients, faster, safer, and more sustainably. Our visionary keynote presentations and best practice case studies will complement engaging panel discussions with different speakers to better understand Pharmacovigilance challenges and solutions from different perspectives, with unique views coming from some of the most experienced and passionate professionals. Our conference will feature numerous assisted formal and informal networking, matchmaking, and breakout sessions to create those critical business friendships that will bring fruitful cooperation and fill that missing piece in our common mission to improve drug safety and quality of life for all.


Who will attend

“Great dialogue on key issues. Everyone shared truthful insight and did not hold back, even on negative experiences.”
Sameer Thapar
Assistant Professor & Advisor, Drug Safety and Pharmacovigilance, Rutgers University
“High-quality speakers and attendees, a great mix between healthcare providers, life science companies, providers of digital health & AI solutions, and investors.”
John Mulcahy
CEO, HealthGenuity
“Unlike some other similar events, I found relevance in every session within your conference. The content was neither too simplistic nor too advanced. The participants and presenters provided a diverse view of the issues that are present for most in this industry.”
Christine Clearwater
Manager, Safety Operations and Vendor Management, Baxter, Global Patient Safety
“Loved it. It was very practical and provided valuable insight into practical methods that are actionable for patient safety.”
Daniel Naranjo
Global Safety Lead, Global Patient Safety Evaluation, Takeda

2023 Speakers

Ben Brown

Founder | Advisor | Patient Safety Advocate
American Society of Pharmacovigilance

Angela Overton

Pharmacovigilance Manager
Prevail InfoWorks

Elena Davison

Sr. Director
Sunovion Pharmaceuticals

Dennis Vargo

Vice President, Head of Drug Safety and Pharmacovigilance

Julie Miller

Deputy Director, Audit and Inspection Readiness Manager, PV Quality - MCCQ

Leila Larbi

Medical Safety Officer - CVM

Michael Glaser

Safety Innovation Technology Director

Nneka Okere

Director Pharmacovigilance

Oleg Zvenigorodsky

Associate Director, Medical Safety
Jazz Pharmaceuticals

Sarah Bradley

Clinical Implementation Specialist
Blue Spark Technologies

Paul Beninger

Tufts University

Sandra Raff

Senior Director, Drug Safety and Pharmacovigilance
Ultragenyx Pharmaceuticals

Kal Elhoregy

Senior Manager, Pharmacovigilance and Medical Quality Compliance
Amneal Pharmaceuticals

Vincent D´Esposito

Associate Director, Pharmacovigilance Training
Otsuka Pharmaceutical Companies

Dawn Mucci

Senior Manager, PV Alliance Management
Jazz Pharmaceuticals

David Lilienfeld

Vice President, Drug safety and Pharmacovigilance
Elevar Therapeutics





Ticket | September 13-14, 2023
$ 2349
  • Access to All Conference Sessions of the Future of Pharmacovigilance Philadelphia Summit
  • Access to Post Conference Networking
  • Conference Materials
  • Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch


  • Present on the Main Stage
  • Hold an exhibit at this event
  • Showcase your Brand in Marketing Material
  • Gain exposure through alternative partnership benefits

event partners

Genpact (NYSE: G) is a global professional services firm delivering the outcomes that transform our clients’ businesses and shape their future. We’re guided by our real-world experience redesigning and running thousands of processes for hundreds of global companies. Our clients – including many in the Fortune Global 500 – partner with us for our unique ability to combine deep industry and functional expertise, leading talent, and proven methodologies to drive collaborative innovation that turns insights into action and delivers outcomes at scale. We create lasting competitive advantages for our clients and their customers, running digitally enabled operations and applying our Data-Tech-AI services to design, build, and transform their businesses. And we do it all with purpose. From New York to New Delhi and more than 30 countries in between, our 115,000+ team is passionate in its relentless pursuit of a world that works better for people. 



Prevail InfoWorks is a global full service CRO that uniquely combines clinical expertise and engineering prowess. For over a decade, we have been biotech’s and biopharma’s one-stop-shop for the most innovative, complete, and flexible clinical trial software solutions.  Prevail’s Single Interface® provides study teams with a single sign-on for real-time reporting, dashboard analytics and process management derived from its automated integration of all your study data sources and systems (EDC, IRT, labs, imaging, EEG, ePRO/eCOA, wearables).  For pharmacovigilance teams, those systems can include Prevail’s Safety Data Management System or any other SDMS.  By seamlessly integrating our SDMS with all other study data, patient safety oversight, signal detection and reporting is easier and more robust; benefiting the patients, study, and you.

American Society of Pharmacovigilance is a national biomedical and healthcare network with membership open to all healthcare professionals. Pharmacovigilance is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse drug events with pharmaceutical products. Adverse drug events annually account for 1 million emergency department visits, 2.2 million hospital admissions, 3.5 million physician office visits and $136 billion U.S. health care costs. Our mission is to rapidly and dramatically reduce the high rate of suffering and mortality due to adverse drug events in the U.S. We represent the unity of different areas of expertise coming together to have a bigger impact on addressing the fourth leading cause of death in the U.S.

get the latest updates & discounts

Subscribe to our newsletter

Our Company